erlotinib hydrochloride has been researched along with Interstitial Nephritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SL; Chuang, CA; Lai, CF; Liao, WY; Lin, WC | 1 |
1 other study(ies) available for erlotinib hydrochloride and Interstitial Nephritis
| Article | Year |
|---|---|
Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Biopsy; Erlotinib Hydrochloride; Glucocorticoids; Humans; Kidney; Kidney Function Tests; Lung Neoplasms; Male; Nephritis, Interstitial; Prednisolone; Recovery of Function; Withholding Treatment | 2020 |